Lung cancer Drug's journey through the body tracked in tiny trial
Knowledge-focused
Not yet recruiting
This early-stage study will give 8 healthy Chinese men a single dose of the experimental lung cancer drug zorifertinib, which has been tagged with a tiny amount of radioactivity. By collecting blood, urine, and stool samples over two weeks, researchers will track exactly how the …
Phase: PHASE1 • Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC